Abstract
Only selected states have used an optional module to address subjective cognitive decline (SCD) on the Behavioral Risk Factor Surveillance System (BRFSS). This study compares SCD with a core measure of cognitive disability (CDis) that has been included on the BRFSS since 2013. Using 2015 BRFSS data from 35 states that asked the module we report the weighted prevalence of SCD and CDis by demographics, chronic conditions, and risk factors among 150,981 respondents ages 45 years or older. We also compare adults with SCD only, CDis only, both, or neither, plus all those reporting either measure on similar health related measures. In addition, results of logistic regression are presented. Weighted prevalence rates and 95% confidence intervals were 11.5% (11.1%-12.0%) for SCD and 10.6% (10.2%-11.0%) for CDis. Approximately half of those reporting one measure reported the other and about one-third of those reporting either fell into each of the 3 mutually exclusive groups. Comparisons indicated a consistent progression from SCD only, to CDis only, to those with both, for measures of chronic conditions, number of SCD-related risk factors, and poorer health status. Logistic regression results for CDis were more like those for adults with SCD who also reported functional difficulties than for all adults with SCD. Conclusion: Although it does not include a timeframe or capture the exact same respondents as SCD, the core measure of CDis appears to be a useful measure of cognitive impairment and may represent adults more adversely affected than those reporting SCD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study received no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Study used publicly available data from the Behavioral Risk Factor Surveillance System cited in references at http://www.cdc.gov/brfss/annual_data/annual_2015.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the study are either available in the paper or on request.
